1.
Oncology
; 45(5): 350-3, 1988.
Article
in English
| MEDLINE
| ID: mdl-3045726
ABSTRACT
In a randomized trial, 105 postmenopausal women with advanced carcinoma of the breast received tamoxifen or aminoglutethimide or combined tamoxifen and aminoglutethimide. No differences were found in the rate of responses and duration of responses between the treatment groups. Toxicity was significantly greater (p less than 0.01) in patients who received aminoglutethimide.
Subject(s)
Aminoglutethimide/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Tamoxifen/therapeutic use , Adult , Aged , Aminoglutethimide/administration & dosage , Aminoglutethimide/adverse effects , Clinical Trials as Topic , Female , Humans , Menopause , Middle Aged , Random Allocation , Tamoxifen/administration & dosage , Tamoxifen/adverse effects
2.
Actas Urol Esp
; 8(1): 53-8, 1984.
Article
in Spanish
| MEDLINE
| ID: mdl-6202110
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Testicular Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Bleomycin/administration & dosage , Cisplatin/administration & dosage , Humans , Male , Neoplasm Recurrence, Local/drug therapy , Prognosis , Testicular Neoplasms/surgery , Vinblastine/administration & dosage
3.
Med Clin (Barc)
; 79(3): 107-9, 1982.
Article
in Spanish
| MEDLINE
| ID: mdl-7109765